Literature DB >> 15818441

Fabry disease. A case report.

Jozica Kotnik1, Franc Kotnik, Robert J Desnick.   

Abstract

Fabry disease is an under-recognized X-linked recessive lysosomal storage disorder resulting from the deficient activity of the enzyme alpha-galactosidase A (alpha-Gal A). The first case of Fabry disease in Slovenia was diagnosed in 1991. This 46 year-old male was referred for dermatologic evaluation of a purpura on his abdomen. He was being treated for proteinuria and cardiac symptoms. The diagnosis of angiokeratoma corporis diffusa (Fabry disease) was made clinically and confirmed by demonstration of the deficient leukocyte alpha-Gal A activity. The patient subsequently developed cerebrovascular symptoms, coronary disease, and renal failure, and died from a recurrent myocardial infarction. Family studies identified several other affected males and carrier female relatives with this X-linked recessive disorder. This case illustrates the typical multi-manifestations of this inherited disease which now can be safely and effectively treated by enzyme replacement therapy. Early diagnosis is important for the most effective treatment of this disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15818441

Source DB:  PubMed          Journal:  Acta Dermatovenerol Alp Pannonica Adriat        ISSN: 1318-4458


  1 in total

1.  Pathological findings in a patient with Fabry disease who died after 2.5 years of enzyme replacement.

Authors:  Raphael Schiffmann; Amy Rapkiewicz; Mones Abu-Asab; Markus Ries; Hasan Askari; Maria Tsokos; Martha Quezado
Journal:  Virchows Arch       Date:  2005-11-29       Impact factor: 4.064

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.